Fikret Buyukkaya
Istanbul, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A novel imaging approach in hyperparathyroidism: [68Ga]Ga-Trivehexin PET/CT.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 15, 2026
Evaluating chronic bone and soft tissue infections with [68Ga]Ga-Pentixafor PET/CT: a head-to-head comparison with scintigraphy.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 17, 2025
Head-to-Head Comparison of 68Ga-FAPI-04 and 68Ga-DOTA-TATE PET/CT in Recurrent Medullary Thyroid Cancer.
Journal: Clinical nuclear medicine
Published: January 08, 2025
Head-to-Head Comparison of 68Ga-FAPI-04 and 68Ga-DOTA-TATE PET/CT in Recurrent Medullary Thyroid Cancer.
Journal: Clinical nuclear medicine
Published: January 08, 2025
[68Ga]Ga-FAPI04 Outperforms [18F]FDG PET/CT for Detecting Nodal Metastasis of Head and Neck Squamous Cell Carcinoma: A Single-Center Experience.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: October 28, 2024
Extensive Pulmonary AL Amyloidosis Mimicking Miliary Tuberculosis: The Diagnostic Utility of 99m Tc-PYP Scintigraphy.
Journal: Clinical nuclear medicine
Published: September 26, 2024
68Ga-Trivehexin PET/CT: a promising novel tracer for primary hyperparathyroidism.
Journal: European journal of nuclear medicine and molecular imaging
Published: May 24, 2024
The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 04, 2023
Utility of 68 Ga-FAPI-04 PET/CT in Adenoid Cystic Carcinoma Compared With 18 F-FDG PET/CT : Two Case Reports.
Journal: Clinical nuclear medicine
Published: May 11, 2023
68 Ga-FAPI04 Versus 68 Ga-DOTATATE PET/CT in a Patient With Multiple Meningioma.
Journal: Clinical nuclear medicine
Published: March 07, 2023
225Ac-Prostate-Specific Membrane Antigen Therapy for Castration-Resistant Prostate Cancer: A Single-Center Experience.
Journal: Clinical nuclear medicine
Published: October 01, 2021
An Analysis for Therapeutic Doses of Patients with Neuroendocrine Tumor Treated with Lutetium 177 (177Lu)-DOTATATE.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: June 17, 2021
Last Updated: 09/26/2026